Reminder - Biosite(R) Incorporated to Conduct 1st Quarter Results Conference Call
April 21 2005 - 7:45AM
PR Newswire (US)
Reminder - Biosite(R) Incorporated to Conduct 1st Quarter Results
Conference Call SAN DIEGO, April 21 /PRNewswire-FirstCall/ --
Biosite Incorporated (NASDAQ:BSTE) announces the following Webcast:
Biosite Incorporated will announce 2005 first quarter results on
Thursday, April 21, 2005 following the close of the market. The
Company will webcast a conference call on the same day (April 21)
at 1:30 p.m. PDT. What: Biosite Announces 1st Quarter Results
Conference Call When: Thursday, April 21, 2005 at 1:30 p.m. PDT
Where:
phx.corporate-ir.net/playerlink.zhtml?c=69046&s=wm&e=1049605
OR http://www.biosite.com/ How: Live over the Internet -- Simply
log onto the web at the address above. Telephonic: US/Canada/Int'l
Dial #: 706-634-7088 Conference ID# 5418856 You may dial *0 at any
time for Operator assistance Contact: Simona Dixon Corporate and
Investor Relations Biosite Incorporated 858.455.4808 ext. 3221
email: If you are unable to participate during the live webcast,
the call will be archived on the Biosite web site
http://www.biosite.com/ until May 12th, 2005 at 2:30 p.m. PDT. The
telephone replay number for U.S. callers is 800-642-1687.
International callers can dial 706-645-9291- Conference ID#
5418856. The telephone replay will be available until May 12, 2005.
Company press releases may be found at http://www.biosite.com/
About Biosite: A leader in the drive to advance diagnosis, Biosite
Incorporated is a research-based company dedicated to the discovery
and development of novel protein-based diagnostic tests that
improve a physician's ability to diagnose debilitating and
life-threatening diseases. The Company combines integrated
discovery and diagnostics businesses to access proteomics research,
identify proteins with high diagnostic utility, develop and
commercialize products and educate the medical community on new
diagnostic approaches that improve health care outcomes. Biosite's
Triage(R) brand rapid diagnostic tests are used in approximately 50
percent of U.S. hospitals and in more than 50 international
markets. Biosite's commercialized products include the Triage BNP
Test to aid in the diagnosis and severity assessment of heart
failure, the Triage Cardiac Panel to aid in the diagnosis of heart
attacks and the Triage Drugs of Abuse Products for the diagnosis of
drug overdose. These tests can deliver critical diagnostic
information to physicians within 10 to 20 minutes. Information
about Biosite can be found at http://www.biosite.com/. (Minimum
Requirements to listen to broadcast: The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp and at
least a 28.8Kbps connection to the Internet.) DATASOURCE: Biosite
Incorporated CONTACT: Nadine Padilla, Vice President, Corporate
& Investor Relations of Biosite Incorporated, +1-858-455-4808,
ext. 3187 Web site: http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biosite (MM) (NASDAQ): 0 recent articles
More Biosite Diagnostics, (MM) News Articles